Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Unknown 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Circulating Tumor DNA 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Circulating Tumor DNA × Clear all
NCT05635630 2022-12-02

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Fudan University

Phase NA Unknown
110 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04555369 2021-07-19

The Value of ctDNA on Chemotherapy Efficacy for mCRC

Fudan University

Phase NA Unknown
300 enrolled

Circulating Tumor DNA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡